Snails—Yes, Snails—Are Helping Unlock Faster Insulins
Scientists have uncovered a potential breakthrough in developing a faster acting insulin in an unusual place: snails. Now, Breakthrough T1D-funded…
Medtronic Panel Discusses Supporting T1D Community During COVID-19
During a recent Breakthrough T1D Facebook Live event, a panel of leaders discussed Medtronic’s efforts to support the T1D community…
TTP399: A Potential First-in-Class Adjunct Therapy in Type 1 Diabetes
Nearly 80 percent of people with type 1 diabetes (T1D) fail to meet HbA1c goals defined by the American Diabetes…
Breakthrough T1D and Gore Invest in Development of Implantable Insulin Delivery System
PhysioLogic Devices, a Breakthrough T1D-funded company that is dedicated to transforming the treatment of type 1 diabetes (T1D), wants to…
FDA Grants Breakthrough Device Status: iLet Bionic Pancreas
Earlier this week, Beta Bionics announced that the Food and Drug Administration (FDA) has granted breakthrough device designation to the…
FDA Authorizes a Second Artificial Pancreas System
The Food and Drug Administration (FDA) today authorized an algorithm that enables the second artificial pancreas system: The Control-IQ™ advanced…
One Less Device: Combining CGM and Insulin Infusion
Breakthrough T1D is funding work to build a better insulin infusion set; the current infusion sets can be uncomfortable and…
Breakthrough T1D Clinical Trial Results Announced at the 55th EASD Meeting
A protein, called glucokinase (or GK), acts as a key regulator of sugar levels in the body. If blood glucose…
FDA Approves Xeris Pharmaceuticals’ Glucagon to Treat Severe Hypoglycemia
On Tuesday, the type 1 diabetes (T1D) community got a helping hand in their ability to avoid severe hypoglycemia when…
Triple Therapy in T1D: Breakthrough T1D Researchers Launch a Clinical Trial
Since its discovery nearly 100 years ago, insulin has been the only effective treatment for type 1 diabetes (T1D). Improvements…
